Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Disease Progression  [Clear All Filters]
2018
Chen LYee, Norby FL, Gottesman RF, et al. "Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study)." J Am Heart Assoc. 2018;7(6).
Kim ED, Tanaka H, Ballew SH, Sang Y, Heiss G, Coresh JJ. "Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2018;72(5):682-690.
Guo L, Akahori H, Harari E, et al. "CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis." J Clin Invest. 2018;128(3):1106-1124.
Warren B, Rebholz CM, Sang Y, Lee AK, Coresh JJ, Selvin E. "Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study." Diabetes Care. 2018;41(8):1646-1653.
Biering-Sørensen T, Kabir M, Waks JW, et al. "Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities)." Circ Arrhythm Electrophysiol. 2018;11(3):e005961.
Garg PK, Norby FL, Polfus LM, et al. "Lipoprotein-associated phospholipase A and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC)." Atherosclerosis. 2018;268:12-18.
Gurka MJ, Guo Y, Filipp SL. "Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes." Cardiovasc Diabetol. 2018;17(1):17.
Morelli T, Moss KL, Preisser JS, Beck JD, Divaris K, Wu D. "Periodontal profile classes predict periodontal disease progression and tooth loss." J Periodontol. 2018;89(2):148-156.
Ding N, Kwak L, Ballew SH, et al. "Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2018;274:86-93.
2017
Chu AY, Tin A, Schlosser P, et al. "Epigenome-wide association studies identify DNA methylation associated with kidney function." Nat Commun. 2017;8(1):1286.
2016
Tangri N, Grams ME, Levey AS, et al. "Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis." JAMA. 2016;315(2):164-74.
Kovesdy CP, Coresh JJ, Ballew SH, et al. "Past Decline Versus Current eGFR and Subsequent ESRD Risk." J Am Soc Nephrol. 2016;27(8):2447-55.
Gurka MJ, Vishnu A, Santen RJ. "Progression of Metabolic Syndrome Severity During the Menopausal Transition." J Am Heart Assoc. 2016;5(8).
2015
Grubbs V, Vittinghoff E, Beck JD, et al. "Association Between Periodontal Disease and Kidney Function Decline in African Americans: The Jackson Heart Study." J Periodontol. 2015;86(10):1126-32.
Rebholz CM, Grams ME, Matsushita K, et al. "Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality." Clin J Am Soc Nephrol. 2015;10(6):941-8.
Rebholz CM, Grams ME, Matsushita K, Selvin E. "Change in novel filtration markers and risk of ESRD." Am J Kidney Dis. 2015;66(1):47-54.
James MT, Grams ME, Woodward M, et al. "A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury." Am J Kidney Dis. 2015;66(4):602-12.
Rebholz CM, Grams ME, Coresh JJ, et al. "Serum fibroblast growth factor-23 is associated with incident kidney disease." J Am Soc Nephrol. 2015;26(1):192-200.
Vishnu A, Gurka MJ. "The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study." Atherosclerosis. 2015;243(1):278-85.
Parrinello CM, Lutsey PL, Ballantyne CM, Folsom AR, Pankow JS. "Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality." Am Heart J. 2015;170(2):380-9.
Power MC, Deal JA, Sharrett ARichey, Jack CR, Knopman D, Mosley TH. "Smoking and white matter hyperintensity progression: the ARIC-MRI Study." Neurology. 2015;84(8):841-8.
Hofer E, Cavalieri M, Bis JC, et al. "White Matter Lesion Progression: Genome-Wide Search for Genetic Influences." Stroke. 2015;46(11):3048-57.
2013
Matsushita K, Ballew SH, Astor BC, et al. "Cohort profile: the chronic kidney disease prognosis consortium." Int J Epidemiol. 2013;42(6):1660-8.
Hamedani AG, Rose KM, B Peterlin L, et al. "Migraine and white matter hyperintensities: the ARIC MRI study." Neurology. 2013;81(15):1308-13.
2012
Rubin J, Matsushita K, Ballantyne CM, Hoogeveen RC, Coresh JJ. "Chronic hyperglycemia and subclinical myocardial injury." J Am Coll Cardiol. 2012;59(5):484-9.
Agarwal SK, Simpson RJ, Rautaharju P, et al. "Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study)." Am J Cardiol. 2012;109(1):105-9.
2008
Köttgen A, Hwang S-J, Rampersaud E, et al. "TCF7L2 variants associate with CKD progression and renal function in population-based cohorts." J Am Soc Nephrol. 2008;19(10):1989-99.
2005
Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E. "APOE genotype and cognitive decline in a middle-aged cohort." Neurology. 2005;64(2):268-76.
Hsu CC, Kao LWH, Coresh J, et al. "Apolipoprotein E and progression of chronic kidney disease." JAMA. 2005;293(23):2892-9.
Merkin S S, Coresh J, Diez Roux AV, Taylor HA, Powe NR. "Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2005;46(2):203-13.
Knopman DS, Mosley TH, Catellier DJ, A Sharrett R. "Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort." Neurology. 2005;65(6):876-81.
Schroeder EB, Chambless LE, Liao D, et al. "Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study." Diabetes Care. 2005;28(3):668-74.